Assignee
DART NEUROSCIENCE LLC
US·11 granted patents·11 pending applications·15 citations·filing 2014–2024
Top patents by PatentIndex Score
22 records- 0187US9963435B2Compounds for therapeutic useDART NEUROSCIENCE LLC·Filed 2016·Granted May 8, 2018·5 cites·10 claims
- 0287US2025122172A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 0385US2025092047A1Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 0484US10981916B2Substituted pyrazolopyrimidinone compounds as PDE2 inhibitorsDART NEUROSCIENCE LLC·Filed 2017·Granted Apr 20, 2021·2 cites·20 claims
- 0582US11434247B1Substituted furanopyrimidine compounds as PDE1 inhibitorsDART NEUROSCIENCE LLC·Filed 2018·Granted Sep 6, 2022·2 cites·24 claims
- 0682US10738018B2Compounds for therapeutic useDART NEUROSCIENCE LLC·Filed 2018·Granted Aug 11, 2020·2 cites·8 claims
- 0781US11685745B2Substituted benzoxazole and benzofuran compounds as PDE7 inhibitorsDART NEUROSCIENCE LLC·Filed 2018·Granted Jun 27, 2023·2 cites·32 claims
- 0879US2023075774A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Application pending·0 cites
- 0978US11365191B2Substituted cyclohexyl compounds as NOP inhibiiorsDART NEUROSCIENCE LLC·Filed 2019·Granted Jun 21, 2022·2 cites·25 claims
- 1078US2025145633A1Substituted furanopyrimidine compounds as pde1 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1177US2025092024A1Substituted cyclohexyl compounds as nop inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1277US2025136604A1Substituted pyrazolopyrimidinone compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1377US2023192698A1Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Application pending·0 cites
- 1476US12319702B2Substituted benzoxazole and benzofuran compounds as PDE7 inhibitorsDART NEUROSCIENCE LLC·Filed 2023·Granted Jun 3, 2025·0 cites·15 claims
- 1575US12006325B2Substituted furanopyrimidine compounds as PDE1 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Granted Jun 11, 2024·0 cites·20 claims
- 1674US11945808B2Substituted cyclohexyl compounds as NOP inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Granted Apr 2, 2024·0 cites·20 claims
- 1773US11279691B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE LLC·Filed 2019·Granted Mar 22, 2022·0 cites·4 claims
- 1872US11999738B2Substituted pyrazolopyrimidinone compounds as PDE2 inhibitorsDART NEUROSCIENCE LLC·Filed 2021·Granted Jun 4, 2024·0 cites·22 claims
- 1962US2021198218A1Compounds for therapeutic useDART NEUROSCIENCE LLC·Filed 2020·Application pending·0 cites
- 2054US2018055434A1Systems and methods for cognitive testingDART NEUROSCIENCE LLC·Filed 2017·Application pending·0 cites
- 2143US2015050626A1Systems, Methods, and Software for Improving Cognitive and Motor AbilitiesDART NEUROSCIENCE LLC·Filed 2014·Application pending·0 cites
- 2241US2019177327A1Substituted methyl pyrazolopyrimidinone and methyl imidazopyrazinone compounds as pde1 inhibitorsDART NEUROSCIENCE LLC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DART NEUROSCIENCE LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →